Ipsen S.A. - Strategy, SWOT and Corporate Finance Report
Summary
Ipsen S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Ipsen S.A. (Ipsen or 'the company') is a pharmaceutical company that offers drugs on targeted therapeutic areas such as oncology, endocrinology, neurology, and primary care. Ipsen provides products for neurodegenerative pathologies, and rheumatology diseases and gastrointestinal disorders. It distributes its drugs to various public hospitals. Ipsen sells its products under Adrovance, Dysport, Decapeptyl, Adenuric, NutropinAq, Smecta, Somatuline and Tanakan brand names. Ipsen has business operations in North America, Asia and Europe. The company is headquartered in Boulogne-Billancourt, Paris, France.
Scope
- Detailed information on Ipsen S.A. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Ipsen S.A. in the form of a SWOT analysis
- An in-depth view of the business model of Ipsen S.A. including a breakdown and examination of key business segments
- Intelligence on Ipsen S.A.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Ipsen S.A., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reaasons to Buy- Gain understanding of Ipsen S.A. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Ipsen S.A. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Ipsen S.A.'s business structure, strategy and prospects.
- Company Snapshot
- Ipsen S.A.: Company Overview
- Ipsen S.A.: Overview and Key Facts
- Ipsen S.A.: Overview
- Ipsen S.A.: Key Facts
- Ipsen S.A.: Key Employees
- Ipsen S.A.: Key Employee Biographies
- Ipsen S.A.: Major Products and Services
- Ipsen S.A.: Company History
- Ipsen S.A.: Management Statement
- Ipsen S.A.: Locations and Subsidiaries
- Ipsen S.A.: Key Competitors
- Ipsen S.A.: Company Analysis
- Ipsen S.A.: Business Description
- Ipsen S.A.: SWOT Analysis
- Ipsen S.A.: SWOT Overview
- Ipsen S.A.: Strengths
- Ipsen S.A.: Weaknesses
- Ipsen S.A.: Opportunities
- Ipsen S.A.: Threats
- Ipsen S.A.: Corporate Financial Deals Activity
- Ipsen S.A.: Financial Deals Overview
- Ipsen S.A.: Targets and Partners
- Ipsen S.A.: Top Deals 2018 - 2022YTD*
- Ipsen S.A.: Advisors
- Ipsen S.A.: Top Legal Advisors
- Ipsen S.A.: Top Financial Advisors
- Ipsen S.A.: Mergers and Acquisitions
- Ipsen S.A.: Corporate Venturing
- Ipsen S.A.: Partnership
- Ipsen S.A.: Divestments
- Ipsen S.A.: Recent Developments
- Ipsen S.A.: News and Events Summary
- Ipsen S.A.: Business Expansion
- Ipsen S.A.: Financial Deals
- Ipsen S.A.: Regulatory and Legal Events
- Ipsen S.A.: Research & Development
- Ipsen S.A.: Strategy and Operations
- Appendix
- Contact Us
- Methodology
- About MarketLine
- List of Tables
- Table 1: Ipsen S.A.: Key Facts
- Table 2: Ipsen S.A.: Key Employees
- Table 3: Ipsen S.A.: Company History
- Table 4: Ipsen S.A.: Locations and Subsidiaries
- Table 5: Ipsen S.A.: Key Competitors
- Table 6: Ipsen S.A.: Deal Activity by Deal Type - Volume (TTM*)
- Table 7: Ipsen S.A.: M&A Activity by Geography (TTM*)
- Table 8: Ipsen S.A.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
- Table 9: Ipsen S.A.: M&A Average Deal Size - Value (US$m)
- Table 10: Ipsen S.A.: Targets and Partners
- Table 11: Ipsen S.A.: Top Deals 2018 - 2022YTD*
- Table 12: Ipsen S.A.: Legal Advisor Ranking by Value (US$m)
- Table 13: Ipsen S.A.: Financial Advisor Ranking by Value (US$m)
- Table 14: Ipsen S.A.: M&A Volume and Value Trend (2018 - YTD*2022)
- Table 15: Ipsen S.A.: M&A Activity by Geography (2018 - YTD*2022)
- Table 16: Ipsen S.A.: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
- Table 17: Ipsen S.A.: Corporate Venturing by Geography (2018 - YTD*2022)
- Table 18: Ipsen S.A.: Partnership Volume and Value Trend (2018 - YTD*2022)
- Table 19: Ipsen S.A.: Partnership Trend by Deal Type (2018 - YTD*2022)
- Table 20: Ipsen S.A.: Divestments Volume and Value Trend (2018 - YTD*2022)
- Table 21: Ipsen S.A.: News and Events Summary
- Table 22: Ipsen S.A.: Business Expansion
- Table 23: Ipsen S.A.: Financial Deals
- Table 24: Ipsen S.A.: Regulatory and Legal Events
- Table 25: Ipsen S.A.: Research & Development
- Table 26: Ipsen S.A.: Strategy and Operations
- List of Figures
- Figure 1: Ipsen S.A.: Deal Activity by Deal Type - Volume (TTM*)
- Figure 2: Ipsen S.A.: M&A Activity by Geography (TTM*)
- Figure 3: Ipsen S.A.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
- Figure 4: Ipsen S.A.: M&A Average Deal Size - Value (US$m)
- Figure 5: Ipsen S.A.: M&A Volume and Value Trend (2018 - YTD*2022)
- Figure 6: Ipsen S.A.: M&A Activity by Geography (2018 - YTD*2022)
- Figure 7: Ipsen S.A.: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
- Figure 8: Ipsen S.A.: Corporate Venturing by Geography (2018 - YTD*2022)
- Figure 9: Ipsen S.A.: Partnership Volume and Value Trend (2018 - YTD*2022)
- Figure 10: Ipsen S.A.: Partnership Trend by Deal Type (2018 - YTD*2022)
- Figure 11: Ipsen S.A.: Divestments Volume and Value Trend (2018 - YTD*2022)